India resumes vaccine exports as domestic stocks build up - officials

  • In US
  • 2021-10-13 14:14:13Z
  • By Reuters

By Sanjeev Miglani

NEW DELHI (Reuters) - India has resumed a small amount of exports of COVID-19 vaccines and will increase exports significantly in the next few months as domestic stocks build up and most of its own large population is inoculated, officials said on Wednesday.

One million shots of Covaxin produced by Indian company Bharat Biotech were shipped to Iran last week, the Indian embassy in Tehran said.

Vaccines have also been sent to Nepal, a government source said, adding that the effort is focused on neighbouring nations.

So far about 4 million shots have been exported, the source said, a small amount in proportion to the expansive vaccine diplomacy Prime Minister Narendra Modi's government launched this year before a second wave of infections forced a halt.

But now that three-quarters of the adult population have had one shot and a third have had both shots, India is poised to play an important role in meeting foreign nations' vaccine requirements, said V.K. Paul, who heads the government's task force on COVID-19.

"As India's needs are met, going forward there will be a generous stockpile of vaccines," Paul told reporters.

The Serum Institute is producing 220 million shots of the Oxford AstraZeneca vaccine per month, up from 150 million in August, and Bharat Biotech is supplying 30 million shots of its home-grown vaccine which is set to rise to 50 million next month, he said.

With a few other locally developed vaccines moving closer to production or clearing regulatory approvals, India is expected to be producing 300-320 million shots a month by early next year -- more than the average 210 million doses it administers to its people each month, the officials said.

"A huge, huge availability of vaccines can be visualised for next year, we expect vaccines made in India to play a significant role in dealing with the pandemic across the world," Paul said.

India is the world's biggest maker of vaccines. Paul said it would in the next two or three days pass the 1 billion mark for vaccine doses administered since the start of its mass campaign to vaccinate all adult Indians.

(Reporting by Sanjeev Miglani; Editing by Timothy Heritage)


More Related News

UK's Bingham expects Omicron vaccine impact to be known in a week
  • US
  • 2021-12-01 15:07:46Z

Kate Bingham, the former head of the UK's COVID-19 Vaccine Taskforce who secured millions of doses for the country, said scientists should know within a week...

Asian markets mostly up, oil rallies as virus and Fed hold attention
Asian markets mostly up, oil rallies as virus and Fed hold attention

Asian markets mostly rose Wednesday while oil prices bounced as traders assess the outlook for the global economy after top drugs makers offered differing...

Global markets fall after Moderna Omicron warning
Global markets fall after Moderna Omicron warning

Stock markets slide after Moderna boss casts doubt on vaccine effectiveness against new variant.

Oxford University says no evidence yet that vaccines won
Oxford University says no evidence yet that vaccines won't protect against severe disease from Omicron
  • US
  • 2021-11-30 11:52:27Z

The University of Oxford on Tuesday said there was no evidence that vaccines would not prevent severe disease from Omicron, but that it was ready to rapidly ...

India's Bharat Biotech studying if Covaxin shot will work on Omicron
  • US
  • 2021-11-30 10:36:12Z

India's Bharat Biotech said on Tuesday it was studying if its Covaxin shot would work against variants of coronavirus such as Omicron, after the CEO of...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply


Top News: US